Journal Articles: In this international, investigator-initiated, parallel-group, open, blinded-outcome assessment trial, we randomly assigned patients who had early atrial fibrillation (diagnosed ≤1 year before enrollment) and cardiovascular conditions to receive either early rhythm control or usual care. Early rhythm control included treatment with antiarrhythmic drugs or atrial fibrillation ablation after randomization. Usual care limited rhythm control to the management of atrial fibrillation–related symptoms. The first primary outcome was a composite of death from cardiovascular causes, stroke, or hospitalization with worsening of heart failure or acute coronary syndrome; the second primary outcome was the number of nights spent in the hospital per year. The primary safety outcome was a composite of death, stroke, or serious adverse events related to rhythm-control therapy. Secondary outcomes, including symptoms and left ventricular function, were also evaluated.

Publish Date or Last Revised January 8, 2024
Resource Type
  • Journal Articles
Therapeutic Area
Atrial Fibrillation
Management
Procedure / Surgery, Rhythm Management
Setting
Electrophysiology Lab, Outpatient
Share